Cancers | Highly Cited Special Issues in 2022–2023 related to Cancer Immunology and Immunotherapy
We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer immunology and immunotherapy in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special issue can be seen below.
|
|
|
|
“Advances in Cancer Immunotherapy” Guest Editor: Dr. Daniela Montagna |
“Cancer Immunotherapy and Immune-Related Adverse Events” Guest Editor: Dr. Shaheen Khan |
|
|
|
|
“Immune Microenvironment and Cancer Progression” Guest Editor: Dr. Esteban Orenes-Piñero |
“Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?” Guest Editor: Dr. Constantin N. Baxevanis |
|
|
|
|
“Immunohistochemical Markers in Endometrial Cancer” Guest Editors: Prof. Dr. Valerio Mais and Dr. Michele Peiretti |
“Prostate-Specific Membrane Antigen (PSMA)” Guest Editor: Prof. Kambiz Rahbar |
|
|
|
|
“Inflammation and the Immunosuppressive Pancreatic Cancer Microenvironment” Guest Editor: Dr. Brian A. Boone and Dr. Tim D. Eubank |
“Engineering the Tumor Immune Microenvironment” Guest Editor: Dr. Scott S. Verbridge |
You are invited to view and submit relevant papers, proposals for some related special issues to the journal Cancers at the following links:
- https://www.mdpi.com/journal/cancers;
- https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.
Cancers Editorial Office